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In this study, we present the novel ﬁndings that chronic ethanol consumption induces mitochondrial
protein hyperacetylation in the kidney and correlates with signiﬁcantly increased renal oxidative stress.
A major proteomic footprint of alcoholic liver disease (ALD) is an increase in hepatic mitochondrial
protein acetylation. Protein hyperacetylation has been shown to alter enzymatic function of numerous
proteins and plays a role in regulating metabolic processes. Renal mitochondrial targets of hyper-
acetylation include numerous metabolic and antioxidant pathways, such as lipid metabolism, oxidative
phosphorylation, and amino acid metabolism, as well as glutathione and thioredoxin pathways. Dis-
ruption of protein lysine acetylation has the potential to impair renal function through metabolic dys-
regulation and decreased antioxidant capacity. Due to a signiﬁcant elevation in ethanol-mediated renal
oxidative stress, we highlight the acetylation of superoxide dismutase, peroxiredoxins, glutathione re-
ductase, and glutathione transferase enzymes. Since oxidative stress is a known factor in ethanol-in-
duced nephrotoxicity, we examined biochemical markers of protein hyperacetylation and oxidative
stress. Our results demonstrate increased protein acetylation concurrent with depleted glutathione, al-
tered Cys redox potential, and the presence of 4-HNE protein modiﬁcations in our 6-week model of
early-stage alcoholic nephrotoxicity. These ﬁndings support the hypothesis that ethanol metabolism
causes an inﬂux of mitochondrial metabolic substrate, resulting in mitochondrial protein hyperacetyla-
tion with the potential to impact mitochondrial metabolic and antioxidant processes.
& 2015 Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
A recent report by the World Health Organization found that
roughly 3.3 million deaths, or 5.9% of all global deaths, were at-
tributable to alcohol consumption [1]. While the dangers of alco-
hol consumption are well known, the precise molecular and cel-
lular mechanisms of tissue injury associated with chronic alcohol
use are highly complex and multifactorial [2–4]. Oxidative stress is
thought to play a role in ethanol-induced renal damage [5].
The liver is a primary target organ of ethanol toxicity, causing
pathologies like steatosis, inﬂammation, and oxidative stress [6].
The onset of alcoholic liver disease (ALD) correlates with chronic
kidney disease; however, the impact of ethanol consumption on
renal function remains largely unexamined [7]. Disruptions inn open access article under the CC
, Campus Box C-238, Aurora,
Fritz).renal function include increased oxidative stress and endothelial
dysfunction [8]. While some studies suggest that chronic ethanol
ingestion is not nephrotoxic, the development of acute kidney
injury (AKI) associates with the mortality of ALD [5,8]. Thus, due to
the fact that chronic ethanol consumption affects organ systems
other than the liver, understanding the mechanisms that lead to
impaired renal function is central to alleviating ethanol-related
mortality.
A major proteomic footprint of ALD is a substantial increase in
mitochondrial protein acetylation [9–11]. Protein hyperacetylation
induces a suppressive effect on many metabolic pathways and
likely plays a key role in regulating mitochondrial processes, such
as antioxidant defense and energy metabolism [12]. Although
enzymatic mechanisms of acetylation occur via acetyltransferase
enzymes, mitochondrial protein acetylation is now hypothesized
to occur mainly through non-enzymatic mechanisms [13–15]. The
mitochondrial deacetylase sirtuin 3 (SIRT3) removes speciﬁc sites
of acetylation; however, SIRT3 expression and activity are un-
changed in a 6-week Lieber–DeCarli model of ethanol toxicity [16].BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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part, as a covalent imprint of metabolic status, such as over-nu-
trition or under-nutrition [17]. Ethanol metabolism provides a
hyper-inﬂux of metabolic substrate through an overabundance of
acetate. Amelioration of excess acetate generated from ethanol
metabolism is primarily handled through lipid synthesis and cel-
lular export into the bloodstream [18]. An intriguing and novel
pathway for compensating with this acetate burden is through the
non-enzymatic acetylation of protein lysine residues via acetyl-
CoA.
Here, we report that ethanol-induced mitochondrial protein
hyperacetylation occurs in the kidney. Utilizing a 6-week murine
model of chronic ethanol consumption, renal mitochondrial pro-
teins were examined by highly sensitive and speciﬁc acetylomics
techniques, revealing ethanol-dependent increases in acetylated
proteins. Pathway analyses demonstrated that hyperacetylated
proteins from renal mitochondria are involved in a number of
metabolic pathways, like the TCA cycle, oxidative phosphorylation,
β-oxidation, and antioxidant defense. A key ﬁnding relating to a
mechanism of alcoholic nephrotoxicity is the hyperacetylation of
numerous antioxidant proteins. These hyperacetylated proteins
include superoxide dismutase (SOD2), peroxiredoxins (PRX), glu-
tathione reductase (GSR), and glutathione transferase (GST) en-
zymes. Given these particular targets of hyperacetylation, we ex-
amined markers of oxidative stress, including increased lipid
peroxidation and altered renal cysteine and glutathione redox
status.2. Materials and methods
2.1. Animal studies
All procedures involving animals were approved by the In-
stitutional Animal Care and Use Committee of the University of
Colorado and were performed in accordance with published Na-
tional Institutes of Health guidelines. Male, C57BL/6J mice were
obtained (Jackson Laboratories) for pair-fed ethanol feeding stu-
dies (n¼12). Mice were fed a modiﬁed Lieber–DeCarli liquid diet
(Bio-Serv, Frenchtown, NJ) for 6 weeks as previously described
[10,19]. Upon study completion, animals were anesthetized via
intraperitoneal injection of sodium pentobarbital and euthanized
via exsanguination. Kidneys were excised, weighed, and subjected
to differential centrifugation using a sucrose gradient for sub-
cellular fractionation to obtain mitochondrial-enriched fractions.
Assays for plasma alanine aminotransferase (ALT) (Sekisui, Lex-
ington, MA), hepatic and plasma triglycerides (Sekisui, Lexington,
MA), plasma creatinine (Cayman, Ann Arbor, Michigan), and blood
ethanol (BioAssay Systems, Hayward, CA) were performed as de-
scribed elsewhere [20].
2.2. Western blotting
For immunoblotting, 25 mg of kidney mitochondrial extract
were separated by standard SDS-PAGE using 12% gels run at 150 V
for 1.5 h and transferred to a Hybond-PVDF membrane (GE
Healthcare, Buckinghamshire, UK). Membranes were blocked for
60 min with TBS/0.1% Tween (TBS-T) and 5% non-fat dry milk
(NFDM). Membranes were then probed with primary antibodies
directed against acetyl-Lys (Cell Signaling, Danvers, MA). A protein
assay (BCA) and paired VDAC Western using the identical condi-
tions were performed to verify load control for the acetyl-Lys
Western. Following 3 washes with TBS-T, a horseradish peroxidase
conjugated secondary was applied for one hour at a 1:10,000 di-
lution and membrane visualization was performed via Storm Im-
ager (GE Lifesciences, Pittsburgh, PA). Band intensities werequantiﬁed using Image J [21].
2.3. Immunohistochemistry
Sections of freshly excised kidney tissue were placed in 10%
neutral buffered formalin (Sigma) for 16 h, followed by incubation
in 70% ethanol overnight. Samples were processed, embedded in
parafﬁn, cut, and sections mounted on slides by the University of
Colorado Anschutz Medical Center Histology Core. Standard he-
matoxylin and eosin (H&E) and periodic-acid Schiff (PAS) staining
was performed. Immunohistochemical characterization was per-
formed using rabbit polyclonal antibodies directed against 4-HNE
(in-house), cytochrome P450-2E1 (Cyp2E1) (Millipore, Billerica,
MA) and acetyl-lysine (Cell Signaling, Woburn, MA) as described
[22–24]. Histologic images were captured on an Olympus BX51
microscope equipped with a four megapixel Macroﬁre digital
camera (Optronics; Goleta, CA) using the PictureFrame Application
2.3 (Optronics). Images in any composite were cropped and as-
sembled in an identical way using Photoshop CS2 (Adobe Systems,
Inc.; Mountain View, CA).
2.4. Determination of renal Cys and GSH redox status
Renal concentrations of cysteine (Cys), cystine (CySS), GSH, and
GSSG were determined using a method by Jones et al.[49]. Brieﬂy,
a small piece of kidney tissue was extracted using 500 μL of a 5%
(w/v) perchloric acid solution containing 0.2 M boric acid and
10 μM γ-Glu-Glu. The tissue was sonicated and protein was pel-
leted via centrifugation. 300 μL of supernatant was then incubated
with iodoacetic acid for 20 min in the dark, then derivatized with
dansyl chloride overnight at room temperature in the dark. Un-
reacted dansyl chloride was extracted using chloroform and the
mixture was centrifuged. The aqueous layer (upper layer) was then
analyzed by HPLC and ﬂuorescence detection. The redox potentials
for Cys (EhCySS) and GSH (EhGSSG) were calculated using the
Nernst equation.
2.5. Acetylomics
Kidney mitochondrial proteins (1 mg) were trypsin-digested
and incubated overnight at 4 °C with acetyl-Lys antibody con-
jugated to agarose (80 μL bead slurry, Immunechem, Burnaby,
British Columbia, Canada) [10]. After incubation, supernatants
were removed and the beads were washed 5 with ice cold PBS.
Peptides were eluted with 0.1 N HCl three times, pooled, evapo-
rated to dryness, resuspended in 0.1% TFA in water, puriﬁed via
C18 ZipTip (EMD Millipore), and resuspended in 0.1% formic acid
in water for LC–MS/MS analysis. Identiﬁcation of acetylated mi-
tochondrial peptides was performed using nHPLC–MS/MS at a
ﬂow rate of 300 nL/min with a gradient of 5–40% 0.1% formic acid
in acetonitrile (ACN) over 240 min on C18 trapping (200.1 mm2)
and analytical columns (2500.075 mm2). The nLC was coupled
to a nano-ESI source and Impact HD Q-TOF mass spectrometer
(Bruker Daltonics, Inc., Billerica, MA). The instrument was oper-
ated using intensity dependent CID MS/MS. MS/MS data analysis
was performed using Mascot (version 2.2.04, Matrixscience) by
Proteinscape (Bruker Daltonics, Billerica, MA). The ﬁnal protein list
included only protein IDs with a probability of 99% or greater and
peptide IDs required a 95% cutoff. Manual validation of each
acetylated peptide ID was performed to discard false positives and
only acetylated peptides were included in our pathway analysis.
The resulting gene list of acetylated proteins was analyzed by the
Database for Annotation, Visualization and Integrated Discovery
(DAVID, v6.7) for biological process enrichment [25]. Signiﬁcance
was determined by fold enrichment 45.0 and Benjamini cor-
rected po0.001.
Table 1
Biochemical markers of ethanol toxicity.
Parameter╪ Control Ethanol
ALT (IU/L) 45.9072.39 84.3777.20b
Liver triglycerides (mmol/L/mg) 0.04470.015 0.07770.036a
Plasma Triglycerides (mmol/L) 0.30170.015 0.42370.020a
b
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Statistical analysis and generation of graphs were performed
using GraphPad Prism 4.02 (GraphPad Software, San Diego, CA).
Differences between control- and ethanol-fed mice were assessed
using an unpaired Student’s t-test. Differences were considered
signiﬁcant if po0.05 as determined using Student’s t-test.Plasma Creatinine (μmol/L) 138.54711.05 230.5478.40
Blood Ethanol (mg/dL) N/A 245.6724.5
Letter superscripts (a) or (b) denote signiﬁcant difference of po0.05 or po0.01.
╪ Data are presented as mean7SEM. Statistical signiﬁcance was determined by
paired Student’s t-test.
Fig. 1. Mitochondrial protein acetylation is increased in renal tissue of ethanol-fed
mice. (A) Western blot (n¼3 mice per group) and (B) Immunohistochemical ana-
lysis with anti-acetyl-lysine antibody demonstrate a signiﬁcant increase in protein
acetylation in renal tissue due to ethanol metabolism (*Po0.05) (size bar¼50 μm).3. Results
3.1. Chronic ethanol consumption alters hepatic and renal
parameters
The data presented in Table 1 details the impact of this 6-week
chronic ethanol model on liver and kidney parameters. Consistent
with previous reports of liver injury using a similar model, a sig-
niﬁcant increase in plasma and hepatic triglycerides, and plasma
ALT was observed [26,27]. Examining renal toxicity, plasma crea-
tinine levels were elevated 1.6-fold following chronic ethanol
consumption. Blood urea nitrogen levels were unchanged (data
not shown), indicating a very early stage of ethanol-mediated
nephrotoxicity. Additionally, blood ethanol was found to be
245.6 mg/dL at the completion of the ethanol challenge, consistent
with other models of ethanol toxicity [20]. Together, these data
demonstrate that this pair-feeding model results in the early-
stages of both hepatic and renal pathology due to ethanol toxicity.
3.2. Ethanol-induced renal mitochondrial protein hyperacetylation
Since nephrotoxicity is associated with alcohol consumption
and ethanol-fed mice display mitochondrial protein hyper-
acetylation, we investigated the acetylation of renal mitochondrial
proteins as a result of ethanol feeding [5, 9]. Chronic ethanol
consumption increased mitochondrial protein acetylation in renal
tissue by approximately 60% compared to controls, p40.05
(Fig. 1). To further characterize ethanol-induced renal protein hy-
peracetylation, immunohistochemistry was performed using renal
tissue sections and a polyclonal antibody to acetyl-lysine. In-
creased renal acetyl-lysine staining was evident in both the
proximal and distal convoluted tubules but not in the intertubule
connective tissue or the vasculature (Fig. 1). Although strong
acetyl-lysine staining was observed in the nuclei of some Loop of
Henle epithelia and Glomerular nuclei, the number of nuclei
strongly stained in the control and ethanol treated animals was
similar.
Since protein acetylation is highly associated with ethanol
metabolism, ethanol-inducible Cyp2E1 was monitored and found
to be highly elevated in the ethanol-fed mice compared to the
pair-fed control mice (Fig. 2) [5]. Cyp2E1 therefore serves as a
robust marker for the presence of renal ethanol metabolism. To
investigate altered renal pathology due to Cyp2E1 induction, PAS
staining was performed. Histologic analysis of PAS stained sections
of kidney did not reveal any grossly abnormal structures, lipid
accumulation, ﬁbrosis, or inﬂammation (Fig. 2). The relative
thickness of the basement membranes of glomerular capillaries of
juxtaglomerular glomeruli was examined, as was the tunica media
thickness of the afferent arterioles for these same glomeruli, and
no changes were observed between control and ethanol-fed mice.
The absence of increased thickness in the basement membrane
suggests that any defect in the ﬁltration membrane is still at a very
early stage. The absence of increased thickness in the afferent ar-
teriole tunica media suggests that there is neither hypertension,
nor the associated increased thickness of the glomerular basement
membranes [28].3.3. Ethanol consumption causes renal lipid peroxidation and sig-
niﬁcant oxidation of renal Cys redox potential (EhCySS) and GSH re-
dox potential (EhGSSG)
We hypothesis that increased protein acetylation suppresses
antioxidant protein function and leads to increased oxidative
stress. Increased generation of reactive oxygen species (ROS) is
known to contribute to the accumulation of lipid peroxidation
products, including 4-HNE, and the subsequent electrophilic
modiﬁcation of both DNA and proteins [16,22,29]. To determine if
4-HNE protein adducts occur concomitant to protein hyper-
acetylation, renal tissue sections were analyzed for 4-HNE mod-
iﬁed protein. As shown in Fig. 2, chronic ethanol exposure resulted
in a slight increase in 4-HNE-protein adduction in proximal and
distal convoluted tubule cells and their nuclei.
After 6-weeks of ethanol consumption, ethanol-fed animals
displayed signiﬁcant reductions in renal Cys, as well as renal CySS
(Fig. 3). These reduced Cys and CySS levels resulted in a signiﬁcant
oxidation of the Cys/CySS redox potential (EhCySS). Ethanol-
mediated changes in GSH, GSSG and the GSH/GSSG redox potential
(EhGSSG) were also determined. As expected, ethanol-fed animals
displayed a signiﬁcant decrease in renal GSH without altering
GSSG levels, thus resulting in a decreased EhGSSG ratio; therefore,
oxidation of EhGSSG was driven primarily by the signiﬁcant de-
pletion of renal GSH. Together, these data indicate that ethanol
consumption signiﬁcantly oxidized both EhCySS and EhGSSG due
to depletion of Cys, CySS and GSH, resulting in an oxidizing en-
vironment in the kidney.
Fig. 2. H&E staining (A and B) did not reveal any grossly abnormal structures, lipid
accumulation, or inﬂammation. As observed by PAS staining, the glomerular
basement membranes (blue arrows) and the muscular layer of the afferent arter-
ioles (yellow arrows) of (C) WT and (D) EtOH fed mice were of similar thicknesses.
Immunohistochemical analysis of kidney tissue demonstrates a major increase in
Cyp2E1 protein levels between control (E) and ethanol feeding groups (F) and
minor increase in 4-hydroxynonenal-protein adducts (G and H) as a result of
ethanol metabolism (400 magniﬁcation). [P¼proximal convoluted tubule,
D¼distal convoluted tubule, G¼glomerulus, size bar¼20 μm (C and D) and 50 μm
(A, B, E, F, G and H).]
Fig. 3. Six weeks of ethanol consumption signiﬁcantly alters renal cysteine and GSH re
chloride derivatization, HPLC, and ﬂuorescence detection. Redox potential for cysteine (E
group; *Po0.05, **Po0.01.
Fig. 4. MS analysis reveals renal mitochondrial protein hyperacetylation during
chronic ethanol consumption. A total of 215 unique acetylated proteins were
identiﬁed by our acetylomics approach. 116 Proteins were found in both control
and ethanol samples, with 16 and 83 found solely in control and ethanol, respec-
tively. In total, 294 and 454 acetylated peptides were identiﬁed in control and
ethanol samples, respectively, revealing a 55% increase in acetylated peptides found
as a result of ethanol consumption.
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A mass spectrometry-based proteomics approach was utilized
to compare acetylated peptides in renal mitochondrial extracts
from control- and ethanol-fed mice. Mitochondrial acetyl-peptide
analysis revealed striking details regarding ethanol-mediated ly-
sine acetylation. A total of 294 acetylated peptides were identiﬁed
in control kidney versus 454 in ethanol kidney. These ﬁndings
establish a 55% increase in acetylated peptides in renal mi-
tochondrial proteins due to ethanol consumption (Supplementary
Table 1), which is in agreement with the observed 60% increase by
the anti-acetyl-Lys Western analysis presented in Fig. 1. In total,
132 and 199 acetylated proteins were detected in the control and
ethanol samples, respectively, and 116 of these proteins were
identiﬁed in both sample groups (Fig. 4). The level of acetyl-Lys
enrichment in kidney tissue represents an increase in both the
number of sites of acetylation per protein as well as an increase in
the number of MS/MS spectra that lead to acetyl-peptide identi-
ﬁcation for a speciﬁc acetylation event.dox status. Cys (A), CySS (B), GSH (D), and GSSG (E) were determined using dansyl
hCySS, C) and GSH (EhGSSG, F) were calculated using the Nernst equation. N¼5 per
Table 2
The top-ranked KEGG pathways or PIR keywords impacted by renal mitochondrial
protein acetylation in control and ethanol groups.
Biological pathway or keyword Benjamini (corrected p-value)
Control Ethanol
Mitochondrion 8.30E87 4.20E133
Transit peptide 3.80E70 4.90E107
Mitochondrion inner membrane 2.70E17 1.10E35
Fatty acid metabolism 2.00E25 9.40E31
Flavoprotein 1.00E17 5.30E23
Lipid metabolism 2.40E18 4.10E20
FAD 1.60E14 1.30E19
Peroxisome 1.30E24 1.90E19
Oxidative phosphorylation 1.70E07 1.80E18
Propanoate metabolism 1.60E07 3.50E16
NAD 1.10E16 1.90E15
Citrate cycle (TCA cycle) 6.60E10 1.90E11
Hydrogen ion transport 3.10E07 4.20E10
Lysine degradation 8.30E09 8.00E10
Transport 7.70E05 4.20E09
ATP synthesis 7.30E06 6.80E09
Tryptophan metabolism 1.50E06 1.40E07
Beta-alanine metabolism 1.20E04 3.20E06
Lyase 2.00E06 4.70E05
Limonene and pinene degradation 4.00E04 1.00E04
KEGG pathway and PIR keywords with enrichment 45.0 and Benjamini o0.001.
Table 3
Acetylation of antioxidant and detox related proteins identiﬁed in kidney mitochondria
Group Cmpda Peptid
SOD2 Cont 1 K.HSLP
Cont 6 K.HHA
Cont 1 R.DFGS
EtOH 27 K.HHA
EtOH 3 K.GELL
EtOH 5 R.DFGS
GPx Cont 4 K.YVRP
Cont 1 R.NALP
EtOH 1 R.DYTE
EtOH 5 K.YVRP
GSTK1 Cont 8 K.AGM
Cont 1 K.LIEN
EtOH 20 K.AGM
EtOH 12 K.AGM
EtOH 2 K.LIEN
GSR EtOH 2 K.VGIQ
PRDX3 Cont 2 K.ELSL
EtOH 7 K.ELSL
PRDX5 Cont 5 K.VNLA
EtOH 4 K.KVN
EtOH 7 K.VNLA
ALDH2 Cont 3 K.FKTI
Cont 3 R.AND
EtOH 4 R.KTFP
EtOH 7 K.TFPT
EtOH 10 R.KTFP
EtOH 3 K.FKTI
EtOH 2 R.AND
Modiﬁed residues are bold and represent: M—methionine oxidation, C—carbamidometh
a Cmpd is assigned by Proteinscape and represents number of MS/MS spectra that l
P.S. Harris et al. / Redox Biology 6 (2015) 33–40 37In order to examine mitochondrial metabolic pathways im-
pacted by acetylation in our renal tissue, the gene list of acetylated
proteins was submitted for pathway analysis via DAVID [25]. Ta-
ble 2 compares the similarities between metabolic pathways
identiﬁed as a result of acetyl-peptide enrichment in renal tissue.
Interestingly, the top-ranked biological processes were similar, but
the level of signiﬁcance for each pathway is different. Bioinfor-
matics analyses for the enrichment of biological processes found a
majority of mitochondrial pathways impacted by acetylation, such
as, lipid metabolism, oxidative phosphorylation, and amino acid
metabolism.
A number of key redox protein targets were identiﬁed from our
acetylomics analysis. Here, numerous antioxidant proteins de-
monstrated an increase in acetylation following ethanol treatment
(Table 3). Our work discovered the hyperacetylation of superoxide
dismutase (SOD2), glutathione peroxidase (GPx), glutathione
S-transferase isoform Kappa 1 (GSTK1), glutathione reductase
(GSR), peroxiredoxin 3 and 5 (PRDX3, PRDX5). GSR was acetylated
only in the ethanol treatment group, and revealed a novel site of
acetylation at Lys332. Of note for SOD2, a inhibitory site Lys122
was only found acetylated in the ethanol group [30]. Mitochon-
drial ethanol metabolizing enzymes were also targets of lysine
acetylation, which included alcohol dehydrogenase (ZADH2), cat-
alase (CATA), and aldehyde dehydrogenase (ALDH2) (Supplemen-
tary data).l isolate from control and ethanol-fed groups.
e sequence AcLys
DLPYDYGALEPHINAQIMQLHHSKHHAAYVNNLNATEEK.Y K53
AYVNNLNATEEKYHEALAK.G K68
FEKFK.E K130
AYVNNLNATEEKYHEALAK.G K68
EAIKR.D K122
FEKFK.E K130
GGGFEPNFTLFEKCEVNGEK.A K112
TPSDDPTALMTDPKYIIWSPVCR.N K146
MNDLQKR.L K62
GGGFEPNFTLFEKCEVNGEK.A K112
STAQAQHFLEKISTQQVK.N K158
TDAACKYGAFGLPTTVAHVDGK.T K177
STAQAQHFLEKISTQQVK.N K158
STAQAQHFLEKISTQQVK.N K158
TDAACKYGAFGLPTTVAHVDGK.T K177
TDEKGHILVDEFQNTNVK.G K332
DDFKGK.Y K92
DDFKGK.Y K92
ELFKGK.K K79
LAELFKGK.K K79
ELFKGK.K K79
EEVVGR.A K430
SKYGLAAAVFTK.D K443
TVNPSTGEVICQVAEGNKEDVDKAVK.A K75
VNPSTGEVICQVAEGNKEDVDKAVK.A K75
TVNPSTGEVICQVAEGNKEDVDKAVK.A K80
EEVVGR.A K430
SKYGLAAAVFTK.D K443
yl, K—acetyl. Novel acetyl-Lys identiﬁcations are highlighted in italic bold.
ead to the ID of the peptide. See Supplementary data for complete MS/MS dataset.
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In this report we demonstrate that ethanol-induced mi-
tochondrial protein hyperacetylation occurs in the kidney during
the early onset of alcohol toxicity. This protein hyperacetylation,
which is known to perturb the function of some mitochondrial
proteins, is believed to be a factor that contributes to ethanol-
mediated mitochondrial dysfunction. Examining biochemical
markers of ethanol toxicity such as plasma ALT and creatinine
conﬁrms the initial stages of liver and kidney dysfunction are oc-
curring in our model; however, as noted above, lack of signiﬁcant
changes in BUN and PAS staining suggests the impact of ethanol on
renal function is at an early stage [5]. Immunohistochemical ana-
lyses also demonstrate increased lipid peroxidation resulting from
oxidative stress, as 4-HNE protein adducts are increased [31].
Furthermore, a signiﬁcant level of oxidative stress is achieved, as
revealed by signiﬁcant oxidation of renal EhCySS and EhGSSG
[20,32]. In aggregate, the present study deﬁnes renal mitochon-
drial protein hyperacetylation and oxidative stress in a model of
alcohol toxicity.
An often-overlooked condition of those hospitalized with ALD
is kidney failure, which contributes signiﬁcantly to patient mor-
tality [33]. While impaired kidney function is a known result of
ethanol toxicity, elucidating mechanisms of ethanol-induced kid-
ney damage requires further attention [8,34,35]. Recent literature
has demonstrated numerous ethanol-related impairments of renal
function. These include uptake and metabolism of folate, electro-
lyte balance, ATPase activity, growth factor and steroid utilization,
and ultrastructural abnormalities, among others [8]. Furthermore,
impaired ﬂuid handling results in ascites and extensive liver da-
mage results in hepatorenal syndrome [34]. The discovery of
ethanol-induced renal protein hyperacetylation provides another
avenue of investigation towards understanding biochemical
pathways of ethanol nephrotoxicity. Additionally, these ﬁndings
contribute to the elucidation of mechanisms contributing to mi-
tochondrial dysfunction due to alcohol metabolism. Importantly, a
recent publication showed that increased renal mitochondrial
protein acetylation occurs in a model of diabetes [36]. Similar
acetylation proﬁles in diabetic nephropathy and ethanol-induced
nephropathy provide a common, yet unexplored, avenue of re-
search regarding the impact of protein acetylation and mi-
tochondrial function. In each instance, a broad array of biological
processes are impacted by hyperacetylation in renal tissue and
likely contributes to renal impairment in both models of ethanol
nephrotoxicity and diabetic nephropathy.
Altered metabolic pathways are highlighted as prominent tar-
gets of renal hyperacetylation in our model. Previously observed
metabolic effects of ethanol metabolism, and consequent increases
in NADH/NADPH, result in altered glucose metabolism, amino acid
metabolism, and β-oxidation [37,38]. Acetyl-targets are found
throughout amino acid and fatty acid metabolism, and oxidative
phosphorylation. Speciﬁcally, increased enrichment of biological
pathways or keywords due to ethanol includes fatty acid meta-
bolism, ﬂavoprotein, lipid metabolism, FAD, oxidative phosphor-
ylation, and propanoate metabolism. Interestingly, propanoate
metabolism includes four enzymes related to acetyl-CoA genera-
tion and hyperacetylation of related proteins likely indicates a
negative feedback from cellular acetate overload. Additionally,
ﬂavoprotein and FAD highlights a metabolic link between the TCA
cycle and oxidative phosphorylation, likely depressed in part due
to the suppressive effect of protein hyperacetylation. The kidney is
a metabolically active tissue, involved in uptake and secretion of
many substances, and these processes utilize transport systems
that require ATP [39]. Therefore, hyperacetylation of proteins di-
rectly related to ATP production, could impair kidney function.
In addition to metabolic dysregulation, oxidative stress hasrecently been highlighted as a key player in ethanol nephrotoxicity
[5,40,41]. Here, we present the novel ﬁnding that antioxidant
proteins are hyperacetylated in the kidney due to ethanol con-
sumption. These include SOD2, GPx, GSTK1, GSR, PRDX3, and
PRDX5. A critical SOD2 lysine residue, K122, was found acetylated
under ethanol-feeding conditions and was not identiﬁed in the
control group. Also, acetylation of K68 was identiﬁed by a 4.5-fold
increase in ethanol-fed mice versus control-fed mice. Acetylation
of these residues is reported to signiﬁcantly inhibit SOD2 activity,
resulting in an increase in both superoxide concentrations and
genomic instability [30,42]. These ﬁndings support, in part, a
previously reported decrease in SOD2 activity during ethanol
toxicity [43]. Furthermore, it has been shown that overexpression
of SOD2 is effective against hepatocyte mitochondrial oxidative
stress, and is protective against alcohol-induced liver injury,
thereby implicating this regulatory site in ROS induced ne-
phrotoxicity [44]. Peroxiredoxins have recently been reported to
display decreased expression in models of ethanol consumption,
contributing to mitochondrial redox imbalance [45,46]. Interest-
ingly, we found PRX3 and PRX5 to be hyperacetylated in kidneys of
ethanol-fed animals, yet further research is needed to uncover
mechanisms of PRX regulation via lysine acetylation. Little is
known regarding the impact of lysine acetylation on GPx, GSTK1,
and GSR; however, glutathione depletion is a known consequence
of ethanol toxicity and remains a prominent target for therapeutic
intervention of ethanol toxicity [20,44]. Interestingly, we report
the ﬁrst ever identiﬁcation of GSR acetylation at K322, which was
identiﬁed only in the ethanol-fed group. This is an important ob-
servation, as chronic ethanol exposure has been shown to cause a
signiﬁcant decrease in GPx activity and GSH concentrations, and
activation of glutathione reductase correlated with a recovery in
GSH levels [47]. Additionally, ethanol consumption resulted in a
16 mV and 26 mV oxidation in EhCySS and EhGSSG, respectively.
This is critically important, because a 30 mV change in the redox
potential (EhGSSG) can result in a 10-fold change in the ratio of
protein dithiol/disulﬁde motif [48]. Therefore, in addition to pro-
tein acetylation, signiﬁcant protein oxidation could occur, resulting
in dramatically altered protein function. These ﬁndings implicate a
critical role for lysine hyperacetylation in ethanol-induced oxida-
tive stress, glutathione regulation, and mitochondrial dysfunction.
The ﬁnding that protein hyperacetylation occurs during dia-
betic nephropathy and also during ethanol-induced kidney da-
mage provides an exciting area of research linking mitochondrial
protein acetylation, metabolic regulation, free radical defenses,
and oxidative stress (Fig. 5). Overall, the ﬁndings presented here
add another aspect to the already complex lysine acetylome
landscape; in particular, the role protein hyperacetylation plays in
ethanol-induced kidney damage. By perturbing mitochondrial
processes through protein acetylation, ethanol metabolism pro-
vides a unique mechanism of enzymatic regulation and metabolic
dysfunction via the non-enzymatic acetylation of lysine residues.
These results raise the possibility of utilizing the regulatory func-
tion of lysine acetylation on protein function as a therapeutic
target to alter the impact of ethanol consumption on mitochon-
drial processes, thereby protecting renal mitochondria as a means
to retard the pathology of acute renal injury associated with high
mortality outcomes in chronic alcohol toxicity. Since acetylation
and oxidative stress are signiﬁcantly increased in renal alcohol
toxicity, future studies will focus on the impact of ethanol-induced
hyperacetylation on antioxidant protein structure and function.
Overall, these ﬁndings support the new hypothesis that due to an
ethanol-mediated inﬂux of acetate, the liver and kidney acetylate
proteins involved in fatty acid, protein, and carbohydrate meta-
bolism, as well as oxidative phosphorylation, and antioxidant
pathways in order to prevent excessive input of respiration sub-
strates. Consequently, deranged metabolism and oxidative stress
Fig. 5. Ethanol metabolism induces renal mitochondrial protein hyperacetylation.
Mounting evidence supports the conclusion ethanol metabolism results in an inﬂux
of carbon metabolic units into the mitochondria and stimulates the non-enzymatic
acetylation of solvent accessible and electrostatic-amenable protein lysine residues.
This hyperacetylation likely plays a role in altered protein function, contributing to
renal dysfunction.
P.S. Harris et al. / Redox Biology 6 (2015) 33–40 39may persist as a negative side effect of the non-enzymatic acet-
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